The Enterprise Value as of December 2024 (TTM) for Cyclerion Therapeutics, Inc. (CYCN) is 5.69M

According to Cyclerion Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.69M. This represents a change of 202.22% compared to the average of 1.88M of the last 4 quarters.

Cyclerion Therapeutics, Inc. (CYCN) Historical Enterprise Value (quarterly & annually)

How has CYCN Enterprise Value performed in the past?

The mean historical Enterprise Value of Cyclerion Therapeutics, Inc. over the last ten years is 106.15M. The current 5.69M Enterprise Value has changed 436.19% with respect to the historical average. Over the past ten years (40 quarters), CYCN's Enterprise Value was at its highest in in the December 2018 quarter at 6.83B. The Enterprise Value was at its lowest in in the September 2023 quarter at -780300.00.

Cyclerion Therapeutics, Inc. (CYCN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cyclerion Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cyclerion Therapeutics, Inc. (CYCN) Average Enterprise Value

How has CYCN Enterprise Value performed in the past?

The current Enterprise Value of Cyclerion Therapeutics, Inc. (CYCN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cyclerion Therapeutics, Inc. (CYCN) Enterprise Value vs. Peers

How is CYCN’s Enterprise Value compared to its peers?

Cyclerion Therapeutics, Inc.’s Enterprise Value is less than Kronos Bio, Inc. (8.02M), less than Larimar Therapeutics, Inc. (214.04M), less than Addex Therapeutics Ltd (7.35M), greater than Achilles Therapeutics plc (-36605455.00), greater than Lipella Pharmaceuticals Inc. (2.38M), less than Senti Biosciences, Inc. (43.14M), less than Fennec Pharmaceuticals Inc. (159.78M), less than Monopar Therapeutics Inc. (122.23M), greater than Applied Molecular Transport Inc. (-5743713.00), less than Cardio Diagnostics Holdings, Inc. (39.22M), less than Sigilon Therapeutics, Inc. (42.21M), greater than Sonnet BioTherapeutics Holdings, Inc. (4.41M), greater than ZyVersa Therapeutics, Inc. (2.53M), less than X4 Pharmaceuticals, Inc. (77.05M), greater than Axcella Health Inc. (-14986000.00), greater than Magenta Therapeutics, Inc. (-114170976.00), less than Kezar Life Sciences, Inc. (28.46M), greater than ContraFect Corporation (-2858930.00), less than ZIVO Bioscience, Inc. (78.24M), less than Theseus Pharmaceuticals, Inc. (138.26M), less than Erasca, Inc. (712.08M), less than Forte Biosciences, Inc. (13.24M),

Build a custom stock screener for Cyclerion Therapeutics, Inc. (CYCN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclerion Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cyclerion Therapeutics, Inc. (CYCN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cyclerion Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.